Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Muscle Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Testing effectiveness (Phase 2)Study completedNCT00400036
What this trial is testing

Dietary Fish Protein in Subjects With Insulin Resistance

Who this might be right for
Insulin ResistanceType 2 Diabetes
Laval University 24
Not applicableAvailableNCT06241339
What this trial is testing

Chronic Effect of Mat Pilates on Neuromotor, Cardiovascular Functions and Inflammatory Markers in Individuals Post-Stroke Stroke and High Blood Pressure

Who this might be right for
StrokeHigh Blood Pressure
Rio de Janeiro State University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06284954
What this trial is testing

Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Who this might be right for
DermatomyositisMyositis
argenx 3
Not applicableNot Yet RecruitingNCT06740656
What this trial is testing

Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature

Who this might be right for
MyositisMyasthaenia GravisNeuropathy+2 more
Central Hospital, Nancy, France 5
Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7
Very early researchNot Yet RecruitingNCT06420154
What this trial is testing

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
First Affiliated Hospital of Wenzhou Medical University 9
Testing effectiveness (Phase 2)Study completedNCT04071574
What this trial is testing

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Who this might be right for
Female InfertilityFemale Infertility Due to Ovulatory DisorderPremature Ovarian Failure+14 more
Lebanese University 200
Not applicableUnknownNCT02797925
What this trial is testing

Mechanisms Behind Development of Tendinopathy

Who this might be right for
Tendinopathy
Bispebjerg Hospital 400
Early research (Phase 1)Looking for participantsNCT06980597
What this trial is testing

OL-108 in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+1 more
Beijing GoBroad Hospital 44
Early research (Phase 1)Ended earlyNCT03912428
What this trial is testing

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

Who this might be right for
MyositisInflammatoryRheumatoid Arthritis+1 more
National Institute of Mental Health (NIMH) 31
Not applicableStudy completedNCT00710411
What this trial is testing

Inflammatory Response After Muscle and Skeleton Trauma

Who this might be right for
Multiple Trauma
University of Ulm 48
Not applicableLooking for participantsNCT07225257
What this trial is testing

Recovery of Physical Function After Critical Illness In Older Adults

Who this might be right for
SepsisAcute Lung Injury(ALI)
University of Kentucky 150
Testing effectiveness (Phase 2)Study completedNCT04628936
What this trial is testing

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 18
Not applicableActive Not RecruitingNCT01171573
What this trial is testing

Investigating Genes in Patients With Polymyositis and Dermatomyositis

Who this might be right for
Myositis
Northern Care Alliance NHS Foundation Trust 1,000
Post-approval studies (Phase 4)Looking for participantsNCT07087912
What this trial is testing

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital 477
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableStudy completedNCT02113111
What this trial is testing

Effects of Fasting on Self Efficacy

Who this might be right for
Chronic PainFibromyalgiaRheumatoid Arthritis+7 more
Universität Duisburg-Essen 120
Not applicableNot Yet RecruitingNCT07473076
What this trial is testing

REgulating Pain Through Neurofeedback in infLammatory Bowel diseasE and Musculoskeletal Dysfunction

Who this might be right for
Inflammatory Bowel Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Not applicableUnknownNCT04022655
What this trial is testing

Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit

Who this might be right for
VasculitisSystemic Lupus ErythematosusMyositis
University of Göttingen 60
Next Page